PG
RGNX icon

Pendal Group’s Regenxbio RGNX Stock Holding History

Pendal Group’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-14,503
Closed -$831K – 470
2019
Q1 		$831K Buy
+14,503
New +$718K 0.01% 316

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $7.71B AUM 4.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
WM
WS Management Jacksonville, Florida $1.14B AUM 139.27% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Pendal Group's RGNX Position: Q2 2019 in Review

Pendal Group sold out of Regenxbio (RGNX) in Q2 2019, closing a stake of 14,503 shares — an estimated $831K sold.

Pendal Group first reported a position in RGNX in Q1 2019 and held it in 1 quarter. The position peaked at $831K in Q1 2019. 186 funds tracked by Wall St. Rank hold RGNX as of Q2 2019.

  • Pendal Group reported no remaining Regenxbio position as of Q2 2019 after selling out during the quarter.
  • Pendal Group sold 14,503 Regenxbio shares in Q2 2019, an estimated $831K.
  • Pendal Group first reported a position in Regenxbio in Q1 2019 and held it in 1 quarter.
  • Pendal Group's Regenxbio position peaked at $831K in Q1 2019.
  • 186 funds tracked by Wall St. Rank held Regenxbio as of Q2 2019.

Based on Pendal Group's 13F filing for Q2 2019, filed 1 Aug 2019.